comparemela.com

Latest Breaking News On - Acasti pharma - Page 5 : comparemela.com

Acasti Pharma (NASDAQ:ACST) Releases Earnings Results

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Up 6.5 % Shares of NASDAQ ACST opened at $2.61 on Tuesday. The firm has a market cap […]

Acasti pharmaCraig hallumAcasti pharma company profileSecurities exchange commissionRenaissance technologiesAcasti pharma incGet free reportMarketwatch earningsFree reportPharma incAcasti pharma dailyNasdaq acst

Acasti Pharma (NASDAQ:ACST) Earns Buy Rating from Analysts at Craig Hallum

Acasti Pharma (NASDAQ:ACST) Earns Buy Rating from Analysts at Craig Hallum
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig hallumAcasti pharmaRenaissance technologiesAcasti pharma incAcasti pharma company profileFree reportGet free reportPharma incAcasti pharma daily

Comparing XBiotech (NASDAQ:XBIT) & Acasti Pharma (NASDAQ:ACST)

Acasti Pharma (NASDAQ:ACST – Get Free Report) and XBiotech (NASDAQ:XBIT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership. Profitability This table compares Acasti Pharma and XBiotech’s […]

United statesAcasti pharmaAcasti pharma incXbiotech incGet free reportGiven acasti pharmaTrue humanAcasti pharma dailyNasdaq acstStock comparisonStock analysis

Acasti Pharma Stock (NASDAQ:ACST), Quotes and News Summary

Acasti Pharma Stock (NASDAQ: ACST) stock price, news, charts, stock research, profile.

Acasti pharma

Acasti Pharma (CVE:ACST) Trading 1 8% Higher

Shares of Acasti Pharma Inc. (CVE:ACST – Get Free Report) were up 1.8% during mid-day trading on Tuesday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously […]

Acasti pharmaAcasti pharma incAcasti pharma company profileGet free reportPharma incAcasti pharma dailyCve acst

vimarsana © 2020. All Rights Reserved.